Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinand Seith

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Diagnostics (Basel, Switzerland)|February 24, 2024
Additional Value of FDG-PET/MRI Complementary to Sentinel Lymphonodectomy for Minimal Invasive Lymph Node Staging in Patients with Endometrial Cancer: A Prospective StudyMatthias Weissinger, Lidia Bala, Sara Yvonne Brucker, et al.
Academic Radiology|June 16, 2021
Early Tumor Size Reduction of at least 10% at the First Follow-Up Computed Tomography Can Predict Survival in the Setting of Advanced Melanoma and ImmunotherapyHaidara Almansour, Saif Afat, Lina Maria Serna-Higuita, et al.
Frontiers in Medicine|July 14, 2023
Non-invasive estimation of split renal function from routine <sup>68</sup>Ga-SSR-PET/CT scansMatthias Weissinger, Kyra Celine Seyfried, Stephan Ursprung, et al.
Radiology|February 22, 2023
Free-breathing Arterial Spin Labeling MRI for the Detection of Pulmonary EmbolismAhmed E Othman, Cecilia Liang, Yasmin Komma, et al.
Medical Image Analysis|August 12, 2017
MR-based respiratory and cardiac motion correction for PET imagingThomas Küstner, Martin Schwartz, Petros Martirosian, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in <sup>18</sup>F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.
Journal of Clinical Medicine|June 28, 2023
Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph NodesMatthias Weissinger, Max Atmanspacher, Werner Spengler, et al.
Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.
Plos One|August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancerOlga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
Theranostics|January 7, 2020
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive <i>in vivo</i><sup>18</sup>F-FDG-PETJohannes Schwenck, Barbara Schörg, Francesco Fiz, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|February 24, 2024
Additional Value of FDG-PET/MRI Complementary to Sentinel Lymphonodectomy for Minimal Invasive Lymph Node Staging in Patients with Endometrial Cancer: A Prospective StudyMatthias Weissinger, Lidia Bala, Sara Yvonne Brucker, et al.
Academic Radiology|June 16, 2021
Early Tumor Size Reduction of at least 10% at the First Follow-Up Computed Tomography Can Predict Survival in the Setting of Advanced Melanoma and ImmunotherapyHaidara Almansour, Saif Afat, Lina Maria Serna-Higuita, et al.
Frontiers in Medicine|July 14, 2023
Non-invasive estimation of split renal function from routine <sup>68</sup>Ga-SSR-PET/CT scansMatthias Weissinger, Kyra Celine Seyfried, Stephan Ursprung, et al.
Radiology|February 22, 2023
Free-breathing Arterial Spin Labeling MRI for the Detection of Pulmonary EmbolismAhmed E Othman, Cecilia Liang, Yasmin Komma, et al.
Medical Image Analysis|August 12, 2017
MR-based respiratory and cardiac motion correction for PET imagingThomas Küstner, Martin Schwartz, Petros Martirosian, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in <sup>18</sup>F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.
Journal of Clinical Medicine|June 28, 2023
Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph NodesMatthias Weissinger, Max Atmanspacher, Werner Spengler, et al.
Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.
Plos One|August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancerOlga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
Theranostics|January 7, 2020
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive <i>in vivo</i><sup>18</sup>F-FDG-PETJohannes Schwenck, Barbara Schörg, Francesco Fiz, et al.
Pageof 5